Vetting burden shifts from regulator to healthcare organisations: independent help exists and matters
Healthcare AI vendors promise solutions that can transform care while keeping patients safe. However, the truth behind these claims is often unclear. As a result, healthcare organisations are left vulnerable to the cost of unexamined AI decisions. Straven & Co, a boutique AI validation firm, helps organisations protect themselves from this risk.
What is happening: The UK’s National Health Service (NHS) has seen an explosion in AI adoption over the past few years, with many hospitals now relying on AI-powered systems to diagnose diseases and develop treatment plans. Despite their promise, these solutions often lack transparency about how they operate or what data they use. This creates significant risks for healthcare providers.
Why it demands action now: Healthcare organisations are exposed to three types of risk when deploying AI in patient care. First, capability risk arises when the technology does not do what was promised. Second, governance risk emerges when the decision cannot be defended before regulatory bodies or courts. Finally, liability risk becomes an issue if healthcare providers are accountable for any errors made by AI systems.
The action: Prudent healthcare organisations need to take immediate steps to mitigate these risks. First, they must assess their existing AI systems and vendor claims using independent validation firms like Straven & Co. Next, they should ensure that the data used in AI decision-making is accurate and representative of patient needs. Finally, they must establish clear governance processes for AI adoption, including transparent communication with patients about how their data is being used.
How Straven helps: Straven & Co offers a unique solution to these risks by providing independent validation services against healthcare organisations’ operations, people, governance obligations, and legal exposure. The firm’s decision-making process examines each proposed AI solution against its vendor claims, ensuring that the technology meets real-world patient needs. With no product to sell and nothing earned by recommending more solutions than necessary, Straven & Co delivers a plain verdict on whether an organisation should proceed with the technology or not.
Straven & Co examines AI decisions before they are acted on: stravenandco.com